ST
SAREPTA THERAPEUTICS INC
SRPT· Health Care· BiotechnologyS&P 600
Close · 10/09/2026
20.52
1D
-6.81%52-week range
14.68 – 25.32
Volume
22,04,000.00
Price history
SRPT
11/08/2026 to 10/09/2026
O 22.02 H 22.02 L 20.28
1W-11.59%
1M+12.62%
3M+35.80%
6M+16.72%
1Y+16.33%
3Y-82.98%
5Y-74.13%
MAX-71.87%
Fundamentals
as of 10/09/2026- Market cap
- $2.17B
- Shares out
- 105.63M
- P/E (forward)
- 8.76
- EPS (trailing)
- -1.29
- Beta
- 0.26
- Profit margin
- -9.77%
- P/B
- 1.42
- Return on equity
- -8.95%
SEC financial statements
61 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- SRPT
- Index
- SP600
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
3 filers · 1 on watchlist · 3 buys · 3 sells · ?: 2 · D: 4
- 14/04/2025Gilbert CisnerosSellSarepta Therapeutics, Inc. - Common Stock$1,001–$15,000
- 14/07/2023Josh GottheimerWBuySarepta Therapeutics, Inc.$1,001–$15,000
- 13/06/2023Josh GottheimerWSellSarepta Therapeutics, Inc.$1,001–$15,000
- 10/04/2023Daniel GoldmanSellSarepta Therapeutics, Inc.$15,001–$50,000
- 06/03/2023Josh GottheimerWBuySarepta Therapeutics, Inc.$1,001–$15,000
- 06/03/2023Daniel GoldmanBuySarepta Therapeutics, Inc.$15,001–$50,000